Melaena following Use of the Cholinesterase Inhibitor Rivastigmine.

Clin Drug Investig

Clinical Pharmacology Unit, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Regional Pharmacovigilance Center, Mater Domini University Hospital, Catanzaro, ItalyOperative Unit ‘Elderly Health Care’, Catanzaro, Italy.

Published: October 2012

Download full-text PDF

Source
http://dx.doi.org/10.2165/00044011-200525030-00008DOI Listing

Publication Analysis

Top Keywords

melaena cholinesterase
4
cholinesterase inhibitor
4
inhibitor rivastigmine
4
melaena
1
inhibitor
1
rivastigmine
1

Similar Publications

An 86-year-old man was admitted with a 3-day history of melaena and syncope. He was haemodynamically compromised and anaemic on presentation. His only medical history was mild Alzheimer's disease diagnosed 6 months prior.

View Article and Find Full Text PDF

Melaena following Use of the Cholinesterase Inhibitor Rivastigmine.

Clin Drug Investig

October 2012

Clinical Pharmacology Unit, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Regional Pharmacovigilance Center, Mater Domini University Hospital, Catanzaro, ItalyOperative Unit ‘Elderly Health Care’, Catanzaro, Italy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!